Biomarkers of heart failure with normal ejection fraction: a systematic review.
about
Understanding heart failure with preserved ejection fraction: where are we today?Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension.Shared biomarkers between female diastolic heart failure and pre-eclampsia: a systematic review and meta-analysis.Circulating levels of tumor necrosis factor-alpha receptor 2 are increased in heart failure with preserved ejection fraction relative to heart failure with reduced ejection fraction: evidence for a divergence in pathophysiologyCharacterizing heart failure in the ventricular volume domainAssociation between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysisBiomarkers and low risk in heart failure. Data from COACH and TRIUMPH.Hyperdynamic left ventricular ejection fraction in the intensive care unit.Myocardial dysfunction occurs prior to changes in ventricular geometry in mice with chronic kidney disease (CKD)Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Human resistin in chemotherapy-induced heart failure in humanized male mice and in women treated for breast cancer.Heart failure highlights in 2012-2013.Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.Candidate biomarkers in heart failure with reduced and preserved ejection fraction.Role of biomarkers in cardiac structure phenotyping in heart failure with preserved ejection fraction: critical appraisal and practical use.Labeling galectin-3 for the assessment of myocardial infarction in rats.A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart.Congestive Heart Failure With Apparently Preserved Left Ventricular Systolic Function: A 10-Year Observational Study.Circulating ACE2 activity correlates with cardiovascular disease development.Association of impaired left ventricular twisting-untwisting with vascular dysfunction, neurohumoral activation and impaired exercise capacity in hypertensive heart disease.Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction.C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.The EJHF last Editor's legacy: how can a high impact factor be built?Galectin-3 Reflects the Echocardiographic Grades of Left Ventricular Diastolic Dysfunction.Early-onset preeclampsia predisposes to preclinical diastolic left ventricular dysfunction in the fifth decade of life: An observational study.Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction.Epidemiology of heart failure with preserved ejection fraction
P2860
Q26766590-80A37591-A2BF-4009-B894-0323F71ADB2DQ33559608-F7BC673A-0DC2-4368-A337-46C2B316081BQ33577443-D56FEC7A-5B5D-47A7-B17E-AF2FD9463127Q33748856-4FB640DE-C5D3-4B4C-BBC5-9A30967A8938Q35135899-996ED9A5-5C1A-4818-B5AE-045F4E835A47Q35201927-882EB2C3-BC3D-4AAF-8A3C-939087EC33F9Q35807149-165D4CF5-B72E-4817-AB9A-0997F77164ADQ35927527-757F8C3B-016C-4E2A-B323-213ED312DDADQ36773711-9036996F-E399-45DD-AC9F-F4B28BF6454CQ37058596-F36F87F5-8352-486F-BD74-857981180BC1Q37240194-172A0056-1D5A-4D75-B724-41695D6FFB65Q38182010-C1227434-E3A4-4B49-8D76-F4BEDA9C8A30Q38183314-6A4FAB4F-39B6-4A06-8431-3F8681118539Q38572500-3D278A03-7939-414A-A2D9-E8CB20F8D1ABQ38614176-CD655CED-DEDC-43AF-A86A-AA20197021EDQ40792117-FB9C5730-0301-4B2A-9F2B-78BAD651DB14Q42745683-A4A0DDB5-950B-4BFC-8049-3298A68D7DEDQ46610908-23670241-FE6D-4173-AC67-A8330EB565B4Q48396569-D5007CB9-EEC3-486A-8969-1E95936D5E0FQ48648294-371D1971-8E16-48A8-88B7-8D5B2BEF55FCQ48725493-5A33991E-3985-4C9E-B379-CF5698513F50Q48787655-52A076B0-D342-47DB-AEE2-0E08C192BEF8Q50584662-D47D2183-2CF1-42D6-8E74-93FBFC836275Q52610863-7521CE81-4FE8-4B07-B2AC-BBDFFECF1CCFQ55332174-83AEF4FB-1EA0-4462-A0E9-178EF033E853Q55499529-B3692418-2837-4DD6-8A31-7400279C658EQ57308303-546B9827-A560-461E-B593-E014AC5BC006
P2860
Biomarkers of heart failure with normal ejection fraction: a systematic review.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Biomarkers of heart failure with normal ejection fraction: a systematic review.
@en
type
label
Biomarkers of heart failure with normal ejection fraction: a systematic review.
@en
prefLabel
Biomarkers of heart failure with normal ejection fraction: a systematic review.
@en
P2093
P2860
P356
P1476
Biomarkers of heart failure with normal ejection fraction: a systematic review.
@en
P2093
Hans L Hillege
Isabella Kardys
Jin M Cheng
K Martijn Akkerhuis
Laura C van Vark
Linda C Battes
Walter J Paulus
P2860
P304
P356
10.1093/EURJHF/HFT106
P50
P577
2013-07-11T00:00:00Z